ACSL3 and lung carcinoma: Here, we found that, in mutant KRAS and in a subset of wild-type KRAS lung cancer cells, high prostaglandin levels are sustained by LPIAT1 activity and depend on the ACSL3-activated AA substrate availability (Fig. 2 and Supplementary Fig. 2).